Interim PET in Hodgkin Lymphoma: Is It So Useless?

Article Properties
  • Language
    English
  • DOI (url)
    10.2967/jnumed.117.190462
  • Publication Date
    2017/03/02
  • Journal
    Journal of Nuclear Medicine
  • Indian UGC (journal)
  • Refrences
    8
  • Michel Meignan
  • Anne Ségolène Cottereau
  • Bénédicte Deau
  • Salim Kanoun
  • Alina Berriolo-Riedinger
  • Olivier Casasnovas
Cite
Meignan, Michel, et al. “Interim PET in Hodgkin Lymphoma: Is It So Useless?”. Journal of Nuclear Medicine, vol. 58, no. 7, 2017, pp. 1180.1-1180, https://doi.org/10.2967/jnumed.117.190462.
Meignan, M., Cottereau, A. S., Deau, B., Kanoun, S., Berriolo-Riedinger, A., & Casasnovas, O. (2017). Interim PET in Hodgkin Lymphoma: Is It So Useless?. Journal of Nuclear Medicine, 58(7), 1180.1-1180. https://doi.org/10.2967/jnumed.117.190462
Meignan M, Cottereau AS, Deau B, Kanoun S, Berriolo-Riedinger A, Casasnovas O. Interim PET in Hodgkin Lymphoma: Is It So Useless?. Journal of Nuclear Medicine. 2017;58(7):1180.1-1180.
Journal Categories
Medicine
Medicine (General)
Medicine
Medicine (General)
Medical physics
Medical radiology
Nuclear medicine
You May Also Like
Refrences
Title Journal Journal Categories Citations Publication Date
Randomized phase III study comparing an early PET driven treatment de-escalation to a not PET-monitored strategy in patients with advanced stages Hodgkin lymphoma: interim analysis of the AHL2011 Lysa study [abstract] 2015
Interim PET-adapted chemotherapy in advanced Hodgkin lymphoma (HL): results of the second interim analysis of the Italian GITIL/FIL HD0607 trial [abstract] Hematological Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Medicine (General)
 2015
10.1200/JCO.2016.68.6394
Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?

 Hematology
  • Education: Education (General)
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Medicine (General)
 13 2016
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale Haematologica
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Medicine (General)
 2014